Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage

Method for determining MIF content

EphB receptor-binding peptides

Replicable expression vector for bacterial expression of a mammalian polypeptide

Nucleic acid encoding modified human thymic stromal lymphopoietin

Growth factor homolog ZVEGF3

S100A9 interaction screening method

Monkey homolog of human oncostatin M and methods of use thereof

USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER

TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS

OSTEOPONTIN FUNCTIONAL EPITOPES, MONOCLONAL ANTIBODIES AGAINST THE EPITOPES AND USES THEREOF

HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 2

T cell activation

OX40R binding agents

Trimeric OX40-immunoglobulin fusion protein and methods of use

Antagonist of ligands and uses thereof

Peptide for anti-angiogenesis and use thereof

ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR

Regulation of angiogenesis with zinc finger proteins

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES

ANTIBODIES TO MAMMALIAN CYTOKINE-LIKE FACTOR 7

Methods for protein refolding

METHODS OF TREATING BONE DISEASE USING VASCULAR ENDOTHELIAL GROWTH FACTOR FUSION CONSTRUCTS

Degranulation inhibitor

Methods of using Fc-cytokine fusion proteins

Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects

MULTIMODALITY MOLECULAR IMAGING WITH THERAPEUTIC CONJUGATES

Multi-modal cancer therapy using viral hitch-hiking

p75NTR MEDIATES EPHRIN-A REVERSE SIGNALING

N-terminal derivatisation of proteins with polysaccharides

CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS

Cytokine-based fusion proteins for treatment of multiple sclerosis

Active antiangiogenic therapy

Use of VEGF-C or VEGF-D in Reconstructive Surgery

Use of VEGF and homologues to treat neuron disorders

METHOD OF IMPROVING EFFICACY OF BIOLOGICAL RESPONSE-MODIFYING PROTEINS AND THE EXEMPLARY MUTEINS

HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION

T cell proteins and nucleotides encoding the same

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants

Method for the immobilization of biologically active polypeptides by using maltose binding protein

Derivatisation of erythropoietin (EPO)

N-terminal polysialylation

Derivatisation of granulocyte colony-stimulating factor

Antibody to mammalian cytokine-like polypeptide-10

Antibodies that immunospecifically bind to B lymphocyte stimulator protein

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

INTERFERON-LIKE PROTEIN ZCYTO21

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

MOLECULES AND CHIMERIC MOLECULES THEREOF

Activated collagen scaffold materials and their special fused active restoration factors

Compositions and methods for the diagnosis and treatment of immune disorders

CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF

METHODS OF PURIFYING PROTEINS FROM EGG WHITE

VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis

IMMUNOINTERACTIVE MOLECULES

Cysteine variants of interleukin-11

METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS

Long Acting Human Interferon Analogs

Monoclonal antibodies to human CTLA-8 (IL-17A)

Regulation of Microphage Migration Inhibitory Factor (MIF) Activity

CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS

Methods for refolding proteins containing free cysteine residues

POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1

Drug-eluting intravascular prostheses and methods of use

Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor

GROWTH FACTOR HOMOLOG ZVEGF4

Expression of heterologous genes according to a targeted expression profile

Methods of stimulating bone growth using ZVEGF4 polypeptides

Linkers

METHODS OF TARGETING BAFF

VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF)-D AND FUNCTIONALLY FRAGMENTS THEREOF FOR BONE REPAIRING

N-terminal modified PEG-TRAIL

Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues

Murine zcytor17 ligand polypeptides

Vascular Endothelial Growth Factor 2

Neutrokine-alpha antibodies and methods of use thereof

Keratinocytes expressing exogenous angiogenic growth factors

Angiogenic peptides and uses thereof

Antibodies to human zcytor17 ligand

Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides

Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue

Resistance Genes

TARGETING VECTOR-PHOSPHOLIPID CONJUGATES

Protease resistant modified erythropoietin polypeptides

Interferon-β mutants with increased anti-proliferative activity

Molecular signature of cancer

RAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES

VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

NOVEL P-SELECTIN LIGAND PROTEIN

Method for inhibiting binding to B-cell receptor

Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonists

MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS

Antibody diagnostic kits and methods of use

Prosaposin as a neurotrophic factor

Method, compositions and classification for tumor diagnostics and treatment

Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6

METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES

Method of using interferon-like protein ZCYTO21 (IL-29) to treat hepatitis C

Methods of treatment using antibodies to neutrokine-alpha

Human Chemotactic Cytokine I Polypeptides

Methods and compositions for regulating T cell subsets by modulating transcription factor activity

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

Fusion protein comprising growth hormone and growth hormone receptor

Long acting human interferon analogs

Protease resistant modified interferon-beta polypeptides

Purification of proteins using preparative reverse phase chromatography (RPC)

Methods for Reducing the Immunogenicity of Cytokines and Removal of Cell Surface Markers

Peptides binding to vascular endothelial growth factor

METHODS FOR DIAGNOSING AND TREATING BLADDER CANCER

Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD

P-selectin ligand protein

METHOD OF TREATING HEPATOCELLULAR CARCINOMA

Recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor fragments

Vascular endothelial growth factor 2

Antibodies to IL-17 polypeptides and therapeutic uses thereof

Antibodies that inhibit TSLP activity

Methods for interfering with rank signaling

POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1

Therapeutic agents comprising pro-apoptotic proteins

Mass producing growth factor using adipose derived adult stem cells

CHIMERA HUMANIZED VASCULAR ENDOTHELIAL GROWTH FACTOR

CHIMERA HUMANIZED VASCULAR ENDOTHELIAL GROWTH FACTOR

Therapeutic uses of factors which inhibit or neutralize MIF activity

Cysteine variants of interferon gamma

Binding compounds, immunogenic compounds and peptidomimetics

Cysteine-containing peptide tag for site-specific conjugation of proteins

Immunogenic Compositions Comprising Hmgb 1 Polypeptides

Modified human four helical bundle polypeptides and their uses

POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1

Methods of contacting β amyloid protein with VEGF

Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses

Prosaposin as a neurotrophic factor

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Vascular endothelial growth factor 2

Nucleic acids encoding P-selectin ligand fusion proteins

Protease resistant interferon beta mutants

Vectors encoding cell growth and adhesion factors for simultaneous growth and adhesion of cells

Antiangiogenic active immunotherapy

Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways

DNA vaccine

VEGF-C ΔRΔRmutants and uses thereof

Vascular endothelial growth factor C (VEGF-C) protein diagnostic

Uses of mammalian cytokine; related reagents

SECRETED PROTEIN CCDC80 REGULATES ADIPOCYTE DIFFERENTIATION

Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Cysteine variants of interferon-gamma

INTERFERON-LIKE PROTEIN ZCYTO21

Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereof

VEGF-RELATED PROTEIN

USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES

Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers

Polynucleotide encoding mammalian cytokine-like polypeptide-10

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

Modified Human Four Helical Bundle Polypeptides and Their Uses

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

Polypeptides, polynucleotides and uses thereof

TANGO 240 nucleic acids and uses thereof

Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2

Screening assay for the identification of inhibitors of macrophage migration inhibitory factor

Modified human four helical bundle polypeptides and their uses

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

Targeting vector-phospholipid conjugates

Use of VEGF-C or VEGF-D in Reconstructive Surgery

Modified Human Four Helical Bundle Polypeptides and Their Uses

Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor

Modified human thymic stromal lymphopoietin

Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use

VEGF-RELATED PROTEIN

Modified Human Interferon Polypeptides and Their Uses

Modified Human Interferon Polypeptides and Their Uses

Modified Human Growth Hormone Polypeptides and Their Uses

Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses

Method for treating liver cirrhosis or interstitial pulmonary fibrosis

Targeting vector-phospholipid conjugates

Modified Human Growth Hormone Polypeptides and Their Uses

Modified Human Growth Hormone Polypeptides and Their Uses

Nucleic acid encoding a human interferon-like protein Zcyto21

Modified human four helical bundle polypeptides and their uses

Prosaposin as a neurotrophic factor

POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1

Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage

Purified mammalian cytokine IL-174 polypeptides

Compositions and methods for the modulation of detrusor activity

Bone mineralization protein expression systems, and methods of studying intracellular signaling pathways induced thereby

IL-17-like cytokine binding compounds and antibodies

Method of treating fibrosis

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

Methods of purifying proteins from egg white

Methods of using VEGF-D polypeptides

ANTI-OSTEOPONTIN ANTIBODY AND USE THEREOF

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use

Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity

Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue

Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells

Compositions and Methods for Inhibiting Angiogenesis

Inflammatory mediator antagonists

Methods for regulating T cell subsets by modulating transcription factor activity

Recombinant Production of Heparin Binding Proteins

Use of VEGF and homologuest to treat neuron disorders

Method of proliferation in neurogenic regions

Pet imaging of vascular endothelial growth factor receptor (VEGFR), compositions for VEGF cancer imaging, and methods of VEGF cancer imaging

Isolation, selection and propagation of animal transgenic stem cells

Biomarkers for Bladder Cancer

INFLAMMATORY MEDIATOR ANTAGONISTS

Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects

Kits for detecting rank nucleic acids

Immunosuppressive Cytokine

Mammalian cells that express VEGF-D polypeptides

Polypeptide promoting vascular endothelial cell growth

CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR

Cytokine Variant Polypeptides

Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents

Methods of targeting multiple cytokines

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A

Use of VEGF and homologues to treat neuron disorders

Cytokine zcytor17 ligand polypeptides

VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTORS HAVING ANTAGONISTIC PROPERTIES, NUCLEIC ACIDS ENCODING THE SAME AND HOST CELLS COMPRISING THOSE NUCLEIC ACIDS

Human Chemokines CKBeta-4 and CKBeta-10/MCP-4

Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same

USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

Multimeric constructs

Compositions comprising conditioned cell culture media and uses thereof

Modified human thymic stromal lymphopoietin

Methods of modulation of the immune system

EG-VEGF nucleic acids and polypeptides and methods of use

Protease-resistant forms of VEGF-D, method of making and method of use

USE OF IL-17 ANTIBODY FOR THE TREATMENT OF CARTILAGE DAMAGED BY OSTEOARTHRITIS

Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof

PHARMACEUTICAL COMPOSITIONS INCLUDING VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR HAVING ALTERERD PHARMACOLOGICAL PROPERTIES

Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases

Method of diagnosing diseases relating to endometriosis

Method for down-regulation of vegf

Platelet promoting protein and the usage thereof

Human Zven polypeptides

Protease resistant interferon beta mutants

Antibodies that bind to a member of the IL-6/G-CSF/MGF family

Cytokine zalpha11 ligand fusion proteins

Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same

CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR

Pharmacokinetic modulation and compositions for modified FN3 polypeptides

Methods of treating diseases with anti-VEGF antibodies

Hypoxia inducible VEGF plasmid for ischemic disease

Inhibitors of type 2 vascular endothelial growth factor receptors

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR VARIANTS AND USES THEREOF

Modified VEGF-A with improved angiogenic properties

MAMMALIAN CYTOKINE-LIKE POLYPEPTIDE-10

Method of inhibiting the activity of growth factor homolog ZVEGF3

CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS

CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS

Novel growth factor and a genetic sequence encoding same

Non-native constitutively active osteopontin

Immunointeractive molecules

Adeno-associated virus-mediated delivery of angiogenic factors

Composition for coordinated VEGF and PDGF expression, and methods of use

EG-VEGF nucleic acids and polypeptides and methods of use

Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances

LIM mineralization protein splice variants

Purification of vascular endothelial growth factor-B

Antibodies to murine zcytor17 ligand

Cysteine muteins in the C-D loop of human interleukin-11

Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS

Multifunctional cytokines

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

Treatment of fibrotic disease

Antibodies to natural killer stimulatory factor

CYTOKINE ZALPHA11 LIGAND

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

Apo-2 ligand/trail variants and uses thereof

Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI)

Prosthetic Grafts

Angiogenic peptides and uses thereof

VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR, THEIR USES, AND PROCESSES FOR THEIR PRODUCTION

Cytokine polypeptides

Murine ZCYTOR17 ligand polypeptides

Regulation of angiogenesis with zinc finger proteins

Cytokine zalpha11 ligand fusion proteins

Cytokine zalpha11 ligand fusion proteins

Nucleic acids encoding IL-174

Method of isolating cytotoxic heterocomplex associated with multiple sclerosis

Eta-1 gene and methods for use

Growth factor homolog zvegf3

Method for expanding hematopoietic cells using cytokine zalpha11 ligand

Compositions and methods for the diagnosis and treatment of immune disorders

METHOD OF TREATING HEPATOCELLULAR CARCINOMA

Cytokine zalpha11 ligand antibodies and methods of use

Compositions including different types of transfer factor

METHOD OF TREATING FIBROSIS

INTERFERON-LIKE PROTEIN ZCYTO21

Modified peptides as therapeutic agents

CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS